Home > Rheumatology > ACR 2020 > Best of the Posters > Children with rheumatic disease have no greater risk of a COVID-19 infection

Children with rheumatic disease have no greater risk of a COVID-19 infection

Presented By
Dr Jonathan S. Hausmann, Harvard Medical School and Boston Children’s Hospital, USA
Conference
ACR 2020
A large international survey including data on 427 children demonstrated that all of them had mild COVID-19 disease, despite the intake of immunosuppressive medication. Besides, few children contracted COVID-19. Globally, fewer cases of COVID-19 have been reported in children (0-17 years) compared with adults. Hospitalisation rates are significantly lower in children than in adults, suggesting that children may have a less severe disease course from COVID-19. However, children with rheumatic diseases face unknown risks in the setting of the pandemic. “Early in the pandemic, we were very concerned about how COVID-19 would affect children with rheumatic diseases,” Dr Jonathan S. Hausmann (Harvard Medical School and Boston Children’s Hospital, USA) explained [1]. They may have an elevated risk of infection due to the underlying disease and also the medications used to treat them. “Early in the pandemic, we were receiving phone calls from worried parents wond...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on